Clinical Trials - PROK

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT05286853A Study of Renal Autologous Cell Therapy (REACT) in Participants With Type 2 Diabetes and Chronic Kidney DiseaseWITHDRAWNPHASE32024-07-172024-09-032024-09-03
NCT05694169A Study of Participants With Chronic Kidney Disease Previously Treated With REACTTERMINATEDPHASE12023-07-112024-05-132024-03-19
NCT05099770Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney DiseaseRECRUITINGPHASE32022-01-052027-022027-02
NCT05018416Study of Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007)COMPLETEDPHASE22021-07-272025-05-202025-05-20
NCT04115345A Study of a Renal Autologous Cell Therapy (REACT) in Patients With Chronic Kidney Disease (CKD) From Congenital Anomalies of the Kidney and Urinary Tract (CAKUT).COMPLETEDPHASE12019-08-132023-01-312023-01-31
NCT03270956A Study of Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney DiseaseCOMPLETEDPHASE22018-04-252022-11-172022-11-17
NCT02836574A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney DiseaseCOMPLETEDPHASE22016-092023-122023-12
NCT02525263Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD)TERMINATEDPHASE22016-072017-082017-05